Drowsiness and fall risk after two doses of study drug
This study tests a medication's effect on alertness and balance by giving healthy adults one dose, running tests for drowsiness and fall risk, then giving a second dose and repeating the tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old
- Weigh at least 120 pounds
- Be in good general health
- Not be taking any medications that affect sleep or wakefulness
- Have no history of sleep disorders, mental health conditions, or seizures
- Be able to eat a high-fat meal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called ORX142 in healthy volunteers to see how it is processed by the body. It helps doctors understand the drug's safety before testing in patients.
This study tests a medication called dexmedetomidine to see how it affects sleep, heart rhythms, and certain blood markers in older adults. The goal is to understand how this drug impacts sleep quality and brain health.
This study tests a new medication called TAK-360 to help adults with narcolepsy type 1 (a condition that causes extreme daytime sleepiness and sudden muscle weakness called cataplexy) feel more alert during the day. The goal is to see if this treatment is safe and effective for managing narcolepsy symptoms.
This study tests a new medicine called TAK-360 for people with narcolepsy type 2 (narcolepsy without cataplexy). It aims to see if the drug safely reduces daytime sleepiness.
This study tests an investigational drug called ALKS 2680 for people with narcolepsy type 2, a condition that causes excessive daytime sleepiness without sudden muscle weakness. The goal is to see if the drug is safe and helps reduce daytime sleepiness.
This study explores how people recover after being given a common sedative called dexmedetomidine. It may help doctors better understand and manage recovery from sedation.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.